A review by the EU’s medicines regulator has concluded the Oxford-AstraZeneca Covid-19 vaccine is “safe and effective”, and its benefits outweigh the risks.
The European Medicines Agency (EMA) conducted its review after 13 EU states suspended use of the vaccine over fears of a link to blood clots.
The EMA found the vaccine was “not associated” with higher risk of clots.
But it said it would continue to study the possibility of such links.
It is up to individual EU countries to decide whether to re-start administering the jab.
On Monday, the three largest EU members – Germany, France and Italy – said they were awaiting the results of the EMA investigation before deciding whether to resume their rollout of the jab.